» Articles » PMID: 2942306

Rationale and Methods for the Use of Nude Mice to Study the Biology and Therapy of Human Cancer Metastasis

Overview
Specialty Oncology
Date 1986 Jan 1
PMID 2942306
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Human neoplasms are biologically heterogeneous. The extensive cellular diversity found in malignant neoplasms is generated by the rapid emergence of clonal subpopulations of tumor cells with different properties that include invasion, metastasis and responsiveness to treatment. Studies in rodent systems have indicated that cancer metastases can be clonal in their origin and that different metastases can originate from different progenitor cells from the primary tumor. This metastatic heterogeneity of tumor cells has many ramifications for studies of tumor biology, in general, and studies of therapy, in particular. The heterogeneous nature of metastatic human neoplasms can now be studied under defined conditions in healthy athymic nude mice. The neoplasms must be free of mouse pathogens and the mice must be kept in specific-pathogen-free conditions. Careful consideration must be given to the intimate tumor-host relationship for each tumor system studied, because the metastatic potential of human neoplasms can vary with the site of implantation into nude mice. Several methods for studying the biology of human neoplasms in the nude mouse are described as well as techniques to assure the success of these studies. The data show that the healthy young nude mouse can be a useful in vivo model for ascertaining the metastatic potential of human neoplasms, for selecting and maintaining cell variants of high metastatic potential from heterogeneous human tumors, and for studying therapeutic agents directed against metastatic cells proliferating in visceral organs.

Citing Articles

Phosphatase regenerating liver 3 participates in Integrinβ1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells.

Chen G, Zhang Z, Li J, Hu C, Gao D, Chen J J Gastrointest Oncol. 2023; 14(2):863-873.

PMID: 37201051 PMC: 10186527. DOI: 10.21037/jgo-22-976.


Long non-coding RNA SPRY4-IT1 promotes proliferation and metastasis in nasopharyngeal carcinoma cell.

Li Y, Liao Z, Wang R, Liang Z, Lin Z, Deng S PeerJ. 2022; 10:e13221.

PMID: 35378932 PMC: 8976472. DOI: 10.7717/peerj.13221.


Xenograft models for pediatric cancer therapies.

McNerney K, Teachey D Fac Rev. 2021; 10:11.

PMID: 33659929 PMC: 7894265. DOI: 10.12703/r/10-11.


The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.

Yashiro M, Matsuoka T, Ohira M Hum Cell. 2018; 31(4):271-281.

PMID: 29876827 DOI: 10.1007/s13577-018-0211-4.


Timeline metastatic progression: in the wake of the « seed and soil » theory.

Amelot A, Terrier L, Mazeron J, Valery C, Cornu P, Carpentier A Med Oncol. 2017; 34(11):185.

PMID: 28986775 DOI: 10.1007/s12032-017-1045-8.


References
1.
DeVore D, Houchens D, Ovejera A, Dill Jr G, Hutson T . Collagenase inhibitors retarding invasion of a human tumor in nude mice. Exp Cell Biol. 1980; 48(5):367-73. DOI: 10.1159/000163001. View

2.
Nicolson G . Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochim Biophys Acta. 1982; 695(2):113-76. DOI: 10.1016/0304-419x(82)90020-8. View

3.
Brambilla C, De Lena M, Rossi A, Valagussa P, Bonadonna G . Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J. 1976; 1(6013):801-4. PMC: 1639498. DOI: 10.1136/bmj.1.6013.801. View

4.
Dexter D, Leith J . Tumor heterogeneity and drug resistance. J Clin Oncol. 1986; 4(2):244-57. DOI: 10.1200/JCO.1986.4.2.244. View

5.
Talmadge J, Fidler I . Cancer metastasis is selective or random depending on the parent tumour population. Nature. 1982; 297(5867):593-4. DOI: 10.1038/297593a0. View